-
Receptor activator of nuclear factor-kappaB ligand (RANKL) directly modulates...
International audience -
Osteosarcoma: current status of immunotherapy and future trends (Review).
International audience -
RANKL directly induces bone morphogenetic protein-2 expression in RANK-expres...
International audience -
Farnesyl diphosphate synthase is involved in the resistance to zoledronic aci...
International audience -
Mifamurtide for the treatment of nonmetastatic osteosarcoma.
International audience -
Molecular alterations associated with osteosarcoma development.
International audience
